{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:02:04Z","timestamp":1789952524669,"version":"4.0.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":82,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Natural Science Foundation of Shandong Province"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose<\/jats:title>\n                    <jats:p>Parkinson\u2019s disease (PD) is a progressive neurodegenerative disorder in which neuroinflammation is recognized as a contributor to clinical progression. This study aimed to characterize the cerebrospinal fluid (CSF) inflammatory profile in mid- to late-stage PD patients and identify specific inflammatory proteins with potential clinical relevance to motor symptoms and disease severity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      In this preliminary retrospective cross-sectional study, CSF samples were obtained from 25 patients with mid- to late-stage PD undergoing evaluation for deep brain stimulation (DBS) (mean disease duration: 10.24\u2009\u00b1\u20094.65 years) and 15 non-PD controls (essential tremor or dystonia) undergoing identical surgical procedures. The levels of 92 inflammation-related proteins were quantified using the Olink proximity extension assay (PEA). Based on the identified differentially expressed proteins (DEPs), we next performed preliminary exploratory comparisons of inflammatory profiles between the postural instability and gait difficulty (PIGD,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) and tremor-dominant (TD,\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200910) PD subtypes. Additionally, preliminary correlation analyses were performed between the DEPs and Movement Disorder Society-Unified Parkinson\u2019s Disease Rating Scale Part-III (MDS-UPDRS-III) scores to generate preliminary observations with limited clinical inference.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Using the Olink platform, 28 DEPs were identified between the PD and non-PD groups (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.05). Subsequent protein-protein interaction network analysis identified IFN-\u03b3 as the central hub. Exploratory descriptive analyses of TD and PIGD subgroups are provided in Additional file 1: Supplementary Figure S1. Among all DEPs, IL-10RB (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.440, 95% CI [0.054, 0.711],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.028), CD8A (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.415, 95% CI [0.024, 0.696],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.039), and CXCL9 (\n                      <jats:italic>r<\/jats:italic>\n                      \u2009=\u20090.414, 95% CI [0.023, 0.696],\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.040) showed moderate correlations with MDS-UPDRS-III scores.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In profiling 92 CSF inflammation-related proteins from 25 advanced PD patients (Hoehn\u2013Yahr 3\u20134) and 11 controls, we identified 28 upregulated DEPs. IFN-\u03b3 emerged as a topologically connected hub in protein-protein interaction networks, and three proteins (IL-10RB, CD8A, CXCL9) showed moderate correlations with motor scores. As cross-sectional descriptive observations, these findings establish a preliminary framework to generate hypotheses for future mechanistic validation and biomarker discovery, while no functional causality can be inferred from the present results.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12883-026-05109-8","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T09:28:24Z","timestamp":1782898104000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A preliminary analysis of the inflammatory protein landscape in the CSF of mid- to late-stage Parkinson\u2019s disease: associations with motor severity and subtypes"],"prefix":"10.1186","volume":"26","author":[{"given":"Yukun","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiting","family":"Bu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruoxi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoqing","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"5109_CR1","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1038\/s41577-022-00684-6","volume":"22 11","author":"MG Tansey","year":"2022","unstructured":"Tansey MG, Wallings RL, Houser MC, Herrick MK, Keating CE, Joers V. Inflammation and immune dysfunction in Parkinson disease. Nat Rev Immunol. 2022;22 11:657\u201373. https:\/\/doi.org\/10.1038\/s41577-022-00684-6.","journal-title":"Nat Rev Immunol"},{"key":"5109_CR2","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1007\/s10072-018-3522-z","volume":"39 11","author":"D Aleksovski","year":"2018","unstructured":"Aleksovski D, Miljkovic D, Bravi D, Antonini A. Disease progression in Parkinson subtypes: the PPMI dataset. Neurol Sci. 2018;39 11:1971\u20136. https:\/\/doi.org\/10.1007\/s10072-018-3522-z.","journal-title":"Neurol Sci"},{"key":"5109_CR3","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1002\/mds.25383","volume":"28 5","author":"GT Stebbins","year":"2013","unstructured":"Stebbins GT, Goetz CG, Burn DJ, Jankovic J, Khoo TK, Tilley BC. How to identify tremor dominant and postural instability\/gait difficulty groups with the movement disorder society unified Parkinson\u2019s disease rating scale: comparison with the unified Parkinson\u2019s disease rating scale. Mov Disord. 2013;28 5:668\u201370. https:\/\/doi.org\/10.1002\/mds.25383.","journal-title":"Mov Disord"},{"key":"5109_CR4","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1001\/jamaneurol.2013.6233","volume":"71 4","author":"MA Thenganatt","year":"2014","unstructured":"Thenganatt MA, Jankovic J. Parkinson disease subtypes. JAMA Neurol. 2014;71 4:499\u2013504. https:\/\/doi.org\/10.1001\/jamaneurol.2013.6233.","journal-title":"JAMA Neurol"},{"key":"5109_CR5","doi-asserted-by":"publisher","unstructured":"Hall S, Janelidze S, Surova Y, Widner H, Zetterberg H, Hansson O. Cerebrospinal fluid concentrations of inflammatory markers in Parkinson\u2019s disease and atypical parkinsonian disorders. Sci Rep. 2018;8(1:13276). https:\/\/doi.org\/10.1038\/s41598-018-31517-z.","DOI":"10.1038\/s41598-018-31517-z"},{"key":"5109_CR6","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3233\/jpd-191724","volume":"10 1","author":"C Martin-Ruiz","year":"2020","unstructured":"Martin-Ruiz C, Williams-Gray CH, Yarnall AJ, Boucher JJ, Lawson RA, Wijeyekoon RS, et al. Senescence and inflammatory markers for predicting clinical progression in Parkinson\u2019s disease: the ICICLE-PD study. J Parkinsons Dis. 2020;10 1:193\u2013206. https:\/\/doi.org\/10.3233\/jpd-191724.","journal-title":"J Parkinsons Dis"},{"key":"5109_CR7","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/s1474-4422(19)30024-9","volume":"18 6","author":"L Parnetti","year":"2019","unstructured":"Parnetti L, Gaetani L, Eusebi P, Paciotti S, Hansson O, El-Agnaf O, et al. CSF and blood biomarkers for Parkinson\u2019s disease. Lancet Neurol. 2019;18 6:573\u201386. https:\/\/doi.org\/10.1016\/s1474-4422(19)30024-9.","journal-title":"Lancet Neurol"},{"issue":"s1","key":"5109_CR8","doi-asserted-by":"publisher","first-page":"S183","DOI":"10.3233\/jpd-223277","volume":"12","author":"M Zimmermann","year":"2022","unstructured":"Zimmermann M, Brockmann K. Blood and cerebrospinal fluid biomarkers of inflammation in Parkinson\u2019s disease. J Parkinsons Dis. 2022;12(s1):S183\u2013200. https:\/\/doi.org\/10.3233\/jpd-223277.","journal-title":"J Parkinsons Dis"},{"key":"5109_CR9","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","volume":"24 9","author":"JH Zhao","year":"2023","unstructured":"Zhao JH, Stacey D, Eriksson N, Macdonald-Dunlop E, Hedman \u00c5K, Kalnapenkis A, et al. Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets. Nat Immunol. 2023;24 9:1540\u201351. https:\/\/doi.org\/10.1038\/s41590-023-01588-w.","journal-title":"Nat Immunol"},{"issue":"4","key":"5109_CR10","doi-asserted-by":"publisher","first-page":"e95192","DOI":"10.1371\/journal.pone.0095192","volume":"9","author":"E Assarsson","year":"2014","unstructured":"Assarsson E, Lundberg M, Holmquist G, Bj\u00f6rkesten J, Thorsen SB, Ekman D, et al. Homogenous 96-plex PEA immunoassay exhibiting high sensitivity, specificity, and excellent scalability. PLoS ONE. 2014;9(4):e95192. https:\/\/doi.org\/10.1371\/journal.pone.0095192.","journal-title":"PLoS ONE"},{"key":"5109_CR11","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik L, Nordberg N, Broberg J, Bj\u00f6rkesten J, Assarsson E, Henriksson S, et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol Cell Proteom. 2021;20:100168. https:\/\/doi.org\/10.1016\/j.mcpro.2021.100168.","journal-title":"Mol Cell Proteom"},{"key":"5109_CR12","doi-asserted-by":"publisher","unstructured":"Santaella A, Kuiperij HB, van Rumund A, Esselink RAJ, van Gool AJ, Bloem BR, et al. Inflammation biomarker discovery in Parkinson\u2019s disease and atypical parkinsonisms. BMC Neurol. 2020;20(1:26). https:\/\/doi.org\/10.1186\/s12883-020-1608-8.","DOI":"10.1186\/s12883-020-1608-8"},{"key":"5109_CR13","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1136\/jnnp-2018-320151","volume":"90 7","author":"E Jabbari","year":"2019","unstructured":"Jabbari E, Woodside J, Guo T, Magdalinou NK, Chelban V, Athauda D, et al. Proximity extension assay testing reveals novel diagnostic biomarkers of atypical parkinsonian syndromes. J Neurol Neurosurg Psychiatry. 2019;90 7:768\u201373. https:\/\/doi.org\/10.1136\/jnnp-2018-320151.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"5109_CR14","doi-asserted-by":"publisher","unstructured":"Pedersen CC, Ushakova A, Skogseth RE, Alves G, Tysnes OB, Aarsland D, et al. Inflammatory biomarkers in newly diagnosed patients with Parkinson disease and related neurodegenerative disorders. Neurol Neuroimmunol Neuroinflamm. 2023;10(4). https:\/\/doi.org\/10.1212\/nxi.0000000000200132.","DOI":"10.1212\/nxi.0000000000200132"},{"key":"5109_CR15","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/mds.20213","volume":"19 9","author":"CG Goetz","year":"2004","unstructured":"Goetz CG, Poewe W, Rascol O, Sampaio C, Stebbins GT, Counsell C, et al. Movement disorder society task force report on the Hoehn and Yahr staging scale: status and recommendations. Mov Disord. 2004;19 9:1020\u20138. https:\/\/doi.org\/10.1002\/mds.20213.","journal-title":"Mov Disord"},{"key":"5109_CR16","doi-asserted-by":"publisher","first-page":"44872","DOI":"10.1038\/srep44872","volume":"7","author":"LJ Zuo","year":"2017","unstructured":"Zuo LJ, Piao YS, Li LX, Yu SY, Guo P, Hu Y, et al. Phenotype of postural instability\/gait difficulty in Parkinson disease: relevance to cognitive impairment and mechanism relating pathological proteins and neurotransmitters. Sci Rep. 2017;7:44872. https:\/\/doi.org\/10.1038\/srep44872.","journal-title":"Sci Rep"},{"key":"5109_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.3390\/ijms241914915","volume":"24","author":"DH Hepp","year":"2023","unstructured":"Hepp DH, van Wageningen TA, Kuiper KL, van Dijk KD, Oosterveld LP, Berendse HW, et al. Inflammatory blood biomarkers are associated with long-term clinical disease severity in Parkinson\u2019s disease. Int J Mol Sci. 2023;24:19. https:\/\/doi.org\/10.3390\/ijms241914915.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"5109_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/0304-3940(96)12706-3","volume":"211","author":"M Mogi","year":"1996","unstructured":"Mogi M, Harada M, Narabayashi H, Inagaki H, Minami M, Nagatsu T. Interleukin (IL)-1 beta, IL-2, IL-4, IL-6 and transforming growth factor-alpha levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson\u2019s disease. Neurosci Lett. 1996;211(1):13\u20136. https:\/\/doi.org\/10.1016\/0304-3940(96)12706-3.","journal-title":"Neurosci Lett"},{"key":"5109_CR19","doi-asserted-by":"publisher","unstructured":"Hei C, Li X, Wang R, Peng J, Liu P, Dong X, et al. Machine learning analysis of gene expression profiles of pyroptosis-related differentially expressed genes in ischemic stroke revealed potential targets for drug repurposing. Sci Rep. 2025;15(1:7035). https:\/\/doi.org\/10.1038\/s41598-024-83555-5.","DOI":"10.1038\/s41598-024-83555-5"},{"key":"5109_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/cddis.2012.123","volume":"3","author":"C Barcia","year":"2012","unstructured":"Barcia C, Ros CM, Annese V, G\u00f3mez A, Ros-Bernal F, Aguado-Llera D, et al. IFN-\u03b3 signaling, with the synergistic contribution of TNF-\u03b1, mediates cell specific microglial and astroglial activation in experimental models of Parkinson\u2019s disease. Cell Death Dis. 2012;3:8. https:\/\/doi.org\/10.1038\/cddis.2012.123.","journal-title":"Cell Death Dis"},{"key":"5109_CR21","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1006\/meth.1999.0837","volume":"19 1","author":"CA Dinarello","year":"1999","unstructured":"Dinarello CA. Interleukin-18. Methods. 1999;19 1:121\u201332. https:\/\/doi.org\/10.1006\/meth.1999.0837.","journal-title":"Methods"},{"key":"5109_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nri1001","volume":"3 2","author":"G Trinchieri","year":"2003","unstructured":"Trinchieri G. Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat Rev Immunol. 2003;3 2:133\u201346. https:\/\/doi.org\/10.1038\/nri1001.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"5109_CR23","doi-asserted-by":"publisher","first-page":"e2250281","DOI":"10.1002\/eji.202250281","volume":"54","author":"H Liu","year":"2024","unstructured":"Liu H, Wang Y, Le Q, Tong J, Wang H. The IFN-\u03b3-CXCL9\/CXCL10-CXCR3 axis in vitiligo: pathological mechanism and treatment. Eur J Immunol. 2024;54(4):e2250281. https:\/\/doi.org\/10.1002\/eji.202250281.","journal-title":"Eur J Immunol"},{"key":"5109_CR24","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1002\/eji.200636251","volume":"37 1","author":"T Kondo","year":"2007","unstructured":"Kondo T, Takata H, Takiguchi M. Functional expression of chemokine receptor CCR6 on human effector memory CD8\u2009+\u2009T cells. Eur J Immunol. 2007;37 1:54\u201365. https:\/\/doi.org\/10.1002\/eji.200636251.","journal-title":"Eur J Immunol"},{"key":"5109_CR25","doi-asserted-by":"publisher","first-page":"8509","DOI":"10.1002\/jcp.27782","volume":"234 6","author":"B Farhood","year":"2019","unstructured":"Farhood B, Najafi M, Mortezaee K. CD8(+) cytotoxic T lymphocytes in cancer immunotherapy: a review. J Cell Physiol. 2019;234 6:8509\u201321. https:\/\/doi.org\/10.1002\/jcp.27782.","journal-title":"J Cell Physiol"},{"key":"5109_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ijms22073789","volume":"22","author":"E Rudnicka","year":"2021","unstructured":"Rudnicka E, Suchta K, Grymowicz M, Calik-Ksepka A, Smolarczyk K, Duszewska AM, et al. Chronic low grade inflammation in pathogenesis of PCOS. Int J Mol Sci. 2021;22:7. https:\/\/doi.org\/10.3390\/ijms22073789.","journal-title":"Int J Mol Sci"},{"key":"5109_CR27","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1006\/cyto.1999.0551","volume":"12 3","author":"T Wang","year":"2000","unstructured":"Wang T, Langley KE, Gourley WK, Klimpel GR. Stem cell factor (SCF) can regulate the activation and expansion of murine intraepithelial lymphocytes. Cytokine. 2000;12 3:272\u201380. https:\/\/doi.org\/10.1006\/cyto.1999.0551.","journal-title":"Cytokine"},{"key":"5109_CR28","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1089\/vim.2018.0124","volume":"32 3","author":"M Irshad","year":"2019","unstructured":"Irshad M, Gupta P, Irshad K. Immunopathogenesis of liver injury during hepatitis C virus infection. Viral Immunol. 2019;32 3:112\u201320. https:\/\/doi.org\/10.1089\/vim.2018.0124.","journal-title":"Viral Immunol"},{"issue":"2","key":"5109_CR29","doi-asserted-by":"publisher","first-page":"e70182","DOI":"10.1111\/cns.70182","volume":"31","author":"Z Zhang","year":"2025","unstructured":"Zhang Z, Peng J, Song Q, Xu Y, Wei Y, Shu Z. Identification of depression subtypes in Parkinson\u2019s disease patients via structural MRI whole-brain radiomics: an unsupervised machine learning study. CNS Neurosci Ther. 2025;31(2):e70182. https:\/\/doi.org\/10.1111\/cns.70182.","journal-title":"CNS Neurosci Ther"},{"key":"5109_CR30","doi-asserted-by":"publisher","unstructured":"Rathnayake D, Chang T, Udagama P. Selected serum cytokines and nitric oxide as potential multi-marker biosignature panels for Parkinson disease of varying durations: a case-control study. BMC Neurol. 2019;19(1:56). https:\/\/doi.org\/10.1186\/s12883-019-1286-6.","DOI":"10.1186\/s12883-019-1286-6"},{"key":"5109_CR31","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1093\/brain\/awaa269","volume":"143 12","author":"J Galiano-Landeira","year":"2020","unstructured":"Galiano-Landeira J, Torra A, Vila M, Bov\u00e9 J. CD8 T cell nigral infiltration precedes synucleinopathy in early stages of Parkinson\u2019s disease. Brain. 2020;143 12:3717\u201333. https:\/\/doi.org\/10.1093\/brain\/awaa269.","journal-title":"Brain"},{"key":"5109_CR32","doi-asserted-by":"publisher","first-page":"1728","DOI":"10.1002\/glia.20587","volume":"55 16","author":"SL Carter","year":"2007","unstructured":"Carter SL, M\u00fcller M, Manders PM, Campbell IL. Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro. Glia. 2007;55 16:1728\u201339. https:\/\/doi.org\/10.1002\/glia.20587.","journal-title":"Glia"},{"key":"5109_CR33","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1038\/nrneurol.2009.160","volume":"5 11","author":"LM Tanabe","year":"2009","unstructured":"Tanabe LM, Kim CE, Alagem N, Dauer WT. Primary dystonia: molecules and mechanisms. Nat Rev Neurol. 2009;5 11:598\u2013609. https:\/\/doi.org\/10.1038\/nrneurol.2009.160.","journal-title":"Nat Rev Neurol"},{"key":"5109_CR34","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.neuroscience.2008.12.041","volume":"164 1","author":"M Carbon","year":"2009","unstructured":"Carbon M, Eidelberg D. Abnormal structure-function relationships in hereditary dystonia. Neuroscience. 2009;164 1:220\u20139. https:\/\/doi.org\/10.1016\/j.neuroscience.2008.12.041.","journal-title":"Neuroscience"}],"container-title":["BMC Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12883-026-05109-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05109-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12883-026-05109-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:36:23Z","timestamp":1789950983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12883-026-05109-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5109"],"URL":"https:\/\/doi.org\/10.1186\/s12883-026-05109-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-9090757\/v1","asserted-by":"object"}]},"ISSN":["1471-2377"],"issn-type":[{"value":"1471-2377","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"11 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All protocols in this study have been approved by the Research Ethics Committee of Jinan Central Hospital Affiliated to Shandong First Medical University (20240924016) and was conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants prior to the experiment.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"595"}}